Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date
symbols : SNYNF save search
United States Human Vaccines Markets, 2018-2021 & Forecast to 2028: Approval/launches of the New Vaccines / Rising Focus on Immunization Programs / Increasing Investments and Government Support
Published: 2022-06-28 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $108.84 |
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
DVAX | News | $12.18 -2.56% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
Cellectis Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D., Ph.D., to its Board of Directors
Published: 2022-06-28 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $108.84 |
|
Health Technology
| Email alert
Add to watchlist
CLLS | News | $2.92 -9.03% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
RLAY | News S | $16.38 -12.27% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
Survey: Digital Workplaces Help Frontline Teams Look Beyond the "Big Quit"
Published: 2022-06-28 (Crawled : 15:00) - prnewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
Hepion Pharmaceuticals Further Strengthens Board with Appointments of Accomplished Biopharmaceutical Executives, Mr. Anand Reddi and Dr. Kaouthar Lbiati
Published: 2022-06-28 (Crawled : 13:00) - contravir.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
HEPA | News | $0.6549 -2.6% 1.13% |
|
Health Technology
|
| O: -1.17%
H: 1.49%
C: -2.99%
G1 Therapeutics Announces Addition of Jacks Lee to Board of Directors
Published: 2022-06-28 (Crawled : 12:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
GTHX | News A | $5.19 -2.99% -0.37% |
|
Health Technology
|
| O: -2.37%
H: 3.18%
C: -3.18%
therapeutics
Press Release: Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease
Published: 2022-06-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
nexviadyme treatment care disease for approved potential
Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD
Published: 2022-06-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
xenpozyme treatment for approved
Sanofi Enters into a Partnering Agreement with Health2Sync
Published: 2022-06-28 (Crawled : 04:00) - prnewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
agreement sanofi
MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published: 2022-06-28 (Crawled : 02:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
ABBV | News | $152.49 -0.42% 0.0% |
|
Health Technology
|
| O: 0.06%
H: 1.27%
C: -0.44%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
pharma
Sanofi: Information concerning the total number of voting rights and shares – May 2022
Published: 2022-06-27 (Crawled : 21:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
AZNCF | $127.2501 |
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
NVS | News | $84.17 -1.3% 0.17% |
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | News | $43.35 -0.8% 0.19% |
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
GLAXF | News | $21.99 |
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
PFE | News | $50.66 -2.35% 0.4% |
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
SPPI A | $0.8436 -1.91% 1.74% |
|
Health Technology
|
| O: 0.0%
H: 2.28%
C: -2.27%
SNYNF | News | $108.84 |
|
Health Technology
|
| O: 4.15%
H: 0.0%
C: 0.0%
BMY | $78.7 -1.6% 0.38% |
|
Health Technology
|
| O: 0.78%
H: 1.72%
C: 0.95%
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
AZN | $65.94 -0.86% 0.21% |
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
immunotherapy report therapy cancer market
COVID-19 Vaccine Leaders Make Progress on Omicron-Specific Boosters
Published: 2022-06-27 (Crawled : 14:20) - biospace.com/
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
SNYNF | News | $108.84 |
|
Health Technology
|
| O: 4.15%
H: 0.0%
C: 0.0%
covid-19 vaccine
Evommune Announces Appointment of Greg Moss as Chief Corporate Strategy and Legal Officer
Published: 2022-06-27 (Crawled : 13:00) - biospace.com/
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
SNYNF | News | $108.84 |
|
Health Technology
|
| O: 4.15%
H: 0.0%
C: 0.0%
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
Published: 2022-06-25 (Crawled : 16:20) - globenewswire.com
SNYNF | News | $108.84 |
|
Health Technology
| Email alert
Add to watchlist
BNTX | News | $139.73 -2.77% 0.4% |
|
Health Technology
| Email alert
Add to watchlist
PFE | News | $50.66 -2.35% 0.4% |
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.41 |
|
Communications
| Email alert
Add to watchlist
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
covid-19 vaccine response
Global Opioids Market to 2027 - Size, Share & Industry Trends Analysis Report
Published: 2022-06-24 (Crawled : 21:00) - prnewswire.com
ENDP | $0.7132 86.17% 6.87% |
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $108.84 |
|
Health Technology
| Email alert
Add to watchlist
MNKKQ | $0.02 |
|
Manufacturing
| Email alert
Add to watchlist
AZN | $65.94 -0.86% 0.21% |
|
Health Technology
| Email alert
Add to watchlist
PFE | News | $50.66 -2.35% 0.4% |
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $127.2501 |
|
Health Technology
| Email alert
Add to watchlist
MNK | $ 0% |
|
n/a
| Email alert
Add to watchlist
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $8.3 |
|
Health Technology
| Email alert
Add to watchlist
trends report market
Sanofi-GSK COVID-19 Vaccine Candidate Effective Against Omicron
Published: 2022-06-24 (Crawled : 16:00) - biospace.com/
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 3.49%
H: 0.0%
C: 0.0%
covid-19 candidate vaccine
Thinking about trading options or stock in Zendesk, Futu, Sanofi, Baidu, or Apple?
Published: 2022-06-24 (Crawled : 14:00) - prnewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 3.49%
H: 0.0%
C: 0.0%
Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine
Published: 2022-06-24 (Crawled : 13:00) - biospace.com/
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 3.49%
H: 0.0%
C: 0.0%
covid-19 vaccine trial results
Intellia and Regeneron Present Updated Interim Data from Phase 1 Study of CRISPR-based NTLA-2001 for the Treatment of Transthyretin (ATTR)
Published: 2022-06-24 (Crawled : 12:00) - biospace.com/
NTLA | $52.05 -2.53% -0.75% |
|
Health Technology
|
| O: 13.34%
H: 5.18%
C: 1.71%
REGN | $594.8 -1.26% 0.02% |
|
Health Technology
|
| O: 3.08%
H: 0.18%
C: 0.07%
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 3.49%
H: 0.0%
C: 0.0%
ntla-2001 treatment for
Intellia and Regeneron Present Updated Interim Data from Phase 1 Study of CRISPR-based NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis Demonstrating that Deep Serum TTR Reductions Remained Durable After a Single Dose
Published: 2022-06-24 (Crawled : 12:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 3.49%
H: 0.0%
C: 0.0%
REGN | $594.8 -1.26% 0.02% |
|
Health Technology
|
| O: 3.08%
H: 0.18%
C: 0.07%
NTLA | $52.05 -2.53% -0.75% |
|
Health Technology
|
| O: 13.34%
H: 5.18%
C: 1.71%
ntla-2001 treatment for
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ACN | News | $283.8 -3.01% 0.07% |
|
Technology Services
ARVL | News | $1.605 -5.03% -0.59% |
|
Manufacturing
BHC | News 4 | $8.83 1.73% 0.11% |
|
Health Technology
BTG | News | $3.56 -2.73% 0.84% |
|
Non-Energy Minerals
CGNT | News | $4.56 -28.97% 4.05% |
|
DELL | News | $48.94 -2.59% 0.0% |
|
Electronic Technology
DKILF | News | $166.37 |
|
Producer Manufacturing
DKILY | News | $16.05 |
|
Manufacturing
GBERF | News | $546.0 |
|
Producer Manufacturing
GBERY | News | $49.49 |
|
Manufacturing
GLAXF | News | $21.99 |
|
Health Technology
GLPI | News 0 d | $46.68 -0.09% 0.0% |
|
Finance
GSK | News | $43.35 -0.8% 0.19% |
|
Health Technology
INCY | News | $75.64 -2.22% 0.93% |
|
Health Technology
INTU | News 4 | $386.39 -4.53% 0.31% |
|
Technology Services
IRCP | News | $2.4984 0.06% |
|
Finance
JCI | News | $48.44 -0.43% 0.0% |
|
Producer Manufacturing
JTEKF | News | $ 0% |
|
Producer Manufacturing
JTEKY | News | $24.29 |
|
Manufacturing
LEA | News | $134.75 0.57% 0.0% |
|
Producer Manufacturing
LLY | News 4 | $317.62 -2.95% -0.03% |
|
Health Technology
NDAQ | News 4 | $154.64 -2.08% -0.23% |
|
Finance
NUVB | News | $3.55 -2.47% 0.0% |
|
NVS | News | $84.17 -1.3% 0.17% |
|
Health Technology
NVSEF | News | $84.01 |
|
Health Technology
PCRFF | News | $8.15 |
|
n/a
PCRFY | News | $8.22 |
|
n/a
PPRUF | News | $534.0 |
|
Consumer Non-Durables
PPRUY | News | $52.24 |
|
Manufacturing
TEVJF | News | $8.3 |
|
Health Technology
TMO | News | $535.77 -1.45% -0.09% |
|
Health Technology
UL | News | $45.33 -1.46% -0.73% |
|
Consumer Non-Durables
UNLYF | News | $47.2225 |
|
Consumer Non-Durables
VTRS | News | $10.91 -1.44% -0.72% |
|
Health Technology
WFC | News 4 | $40.18 -0.15% 0.15% |
|
Finance
ZTS | News 4 | $170.12 -2.01% 0.96% |
|
Health Technology